{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:06:24Z","timestamp":1791597984578,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Canadian Institutes of Health Research (CIHR) HIV\/AIDS Research Initiative","award":["190374"],"award-info":[{"award-number":["190374"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-24935-y","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:53:29Z","timestamp":1761742409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Using the socioecological model to guide service delivery improvements to the prison needle exchange program in Canada: insights from multi-level stakeholders"],"prefix":"10.1186","volume":"25","author":[{"given":"Nadine","family":"Kronfli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Lafferty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Stoov\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Hajarizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"24935_CR1","unstructured":"United Nations Office on Drugs and Crime. A handbook for starting and managing needle and syringe programmes in prisons and other closed settings: UNODC; 2015. Retrieved from: https:\/\/www.unodc.org\/documents\/hiv-aids\/publications\/Prisons_and_other_closed_settings\/ADV_COPY_NSP_PRISON_AUG_2014.pdf. Accessed 9 Nov 2024."},{"key":"24935_CR2","unstructured":"World Health Organization. Recommended package of interventions for HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for people in prisons and other closed settings: Policy brief. 2023. Retrieved from: https:\/\/www.who.int\/publications\/i\/item\/9789240071858. Accessed 9 Nov 2024."},{"issue":"1","key":"24935_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/epirev\/mxx019","volume":"40","author":"JV Lazarus","year":"2018","unstructured":"Lazarus JV, Safreed-Harmon K, Hetherington L, Bromberg DJ, Ocampo D, Graf N, et al. Health outcomes for clients of needle and syringe programs in prisons. Epidemiol Rev. 2018;40(1):96\u2013104. https:\/\/doi.org\/10.1093\/epirev\/mxx019.","journal-title":"Epidemiol Rev"},{"key":"24935_CR4","unstructured":"Harm Reduction International. The global state of harm reduction: 2024. 9th edition. 2024. Retrieved from: https:\/\/hri.global\/wp-content\/uploads\/2024\/10\/HRI-GSHR-2024_Full-Report_Final.pdf. Accessed 9 Nov 2024."},{"issue":"1","key":"24935_CR5","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1016\/S2468-2667(24)00275-5","volume":"10","author":"N Kronfli","year":"2025","unstructured":"Kronfli N, Bromberg D, Wolff H, Montanari L, Altice F. Improving implementation of needle and syringe programmes to expand, scale-up, and sustain evidence-based prevention interventions for HIV and hepatitis C in prisons. Lancet Public Health. 2025;10(1):e63\u201370. https:\/\/doi.org\/10.1016\/S2468-2667(24)00275-5.","journal-title":"Lancet Public Health"},{"issue":"5","key":"24935_CR6","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/add.14830","volume":"115","author":"NA Breta\u00f1a","year":"2020","unstructured":"Breta\u00f1a NA, Gray RR, Cunningham EB, Betz-Stablein B, Ribeiro R, Graw F, et al. Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study. Addiction. 2020;115(5):901\u201313. https:\/\/doi.org\/10.1111\/add.14830.","journal-title":"Addiction"},{"issue":"3","key":"24935_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/liv.15469","volume":"43","author":"J Stone","year":"2023","unstructured":"Stone J, Lim AG, Dore GJ, Borquez A, Geddes L, Gray R, et al. Prison-based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: a modelling study. Liver Int. 2023;43(3):569\u201379. https:\/\/doi.org\/10.1111\/liv.15469.","journal-title":"Liver Int"},{"key":"24935_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/s2468-1253(21)00077-7","volume":"6","author":"B Hajarizadeh","year":"2021","unstructured":"Hajarizadeh B, Grebely J, Byrne M, Marks P, Amin J, McManus H, et al. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study. Lancet Gastroenterol Hepatol. 2021;6:533\u201346. https:\/\/doi.org\/10.1016\/s2468-1253(21)00077-7.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"24935_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/cld.1023","volume":"17","author":"SR Bartlett","year":"2021","unstructured":"Bartlett SR, Buxton J, Palayew A, Picchio CA, Janjua NZ, Kronfli N. Hepatitis C virus prevalence, screening, and treatment among people who are incarcerated in Canada: leaving no one behind in the direct-acting antiviral era. Clin Liver Dis. 2021;17:75\u201380. https:\/\/doi.org\/10.1002\/cld.1023.","journal-title":"Clin Liver Dis"},{"key":"24935_CR10","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.171142","volume":"190","author":"N Kronfli","year":"2018","unstructured":"Kronfli N, Cox J. Care for people with hepatitis c in provincial and territorial prisons. Can Med Assoc J. 2018;190:E93\u20134. https:\/\/doi.org\/10.1503\/cmaj.171142.","journal-title":"Can Med Assoc J"},{"key":"24935_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3138\/canlivj.2019-0007","volume":"2","author":"N Kronfli","year":"2019","unstructured":"Kronfli N, Buxton JA, Jennings L, Kouyoumdjian F, Wong A. Hepatitis C virus (HCV) care in Canadian correctional facilities: where are we and where do we need to be? Canadian Liver Journal. 2019;2:171\u201383. https:\/\/doi.org\/10.3138\/canlivj.2019-0007.","journal-title":"Canadian Liver Journal"},{"key":"24935_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3138\/canlivj-2020-0035","volume":"4","author":"N Kronfli","year":"2021","unstructured":"Kronfli N, Dussault C, Bartlett S, Fuchs D, Kaita K, Harland K, et al. Disparities in hepatitis C care across Canadian provincial prisons: implications for hepatitis C micro-elimination. Canadian Liver Journal. 2021;4:292\u2013310. https:\/\/doi.org\/10.3138\/canlivj-2020-0035.","journal-title":"Canadian Liver Journal"},{"key":"24935_CR13","unstructured":"Office of the Correctional Investigator. Annual Report 2018\u20132019. Retrieved from: https:\/\/oci-bec.gc.ca\/en\/content\/office-correctional-investigator-annual-report-2018-2019. Accessed 9 Nov 2024."},{"key":"24935_CR14","unstructured":"Correctional Service Canada. Prevalence rates of infectious diseases among offenders in federal custody. 2023. Retrieved from: https:\/\/www.canada.ca\/en\/correctional-service\/corporate\/library\/research\/emerging-results\/23-30.html. Accessed 23 Jan 2025."},{"key":"24935_CR15","unstructured":"Public Health Agency of Canada. Government of Canada's sexually transmitted and blood-borne infections (STBBI) action plan 2024\u20132030. 2024. Retrieved from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/sexually-transmitted-blood-borne-infections-action-plan-2024-2030.html. Accessed 9 Nov 2024."},{"key":"24935_CR16","doi-asserted-by":"publisher","first-page":"E1401","DOI":"10.1503\/cmaj.240648","volume":"196","author":"F Houdroge","year":"2024","unstructured":"Houdroge F, Kronfli N, Stoov\u00e9 M, Scott N. Cost\u2013benefit analysis of Canada\u2019s Prison Needle Exchange Program for the prevention of hepatitis C and injection-related infections. CMAJ. 2024;196:E1401-12. https:\/\/doi.org\/10.1503\/cmaj.240648.","journal-title":"CMAJ."},{"key":"24935_CR17","unstructured":"Correctional Service Canada. Prison Needle Exchange Program. 2024. Retrieved from: https:\/\/www.canada.ca\/en\/correctional-service\/programs\/offenders\/health-services\/prison-needle-exchange-program.html. Accessed 7 Aug 2025."},{"key":"24935_CR18","doi-asserted-by":"publisher","unstructured":"Chu SKH, Elliott R, Simons S, Rowe J, Edmiston L, Stratton T. Flawed by design: Canada's first prison needle exchange program. Paper presented at the 24th International AIDS Conference, Montreal, Canada; 2022. https:\/\/doi.org\/10.1002\/jia2.25935.","DOI":"10.1002\/jia2.25935"},{"key":"24935_CR19","unstructured":"Thompson S. PNEP\/OPS Progress Update. Satellite Session: Implementing needle and syringe programs in Canada: Voices From the Front Line. In: The 24th International AIDS Conference. Montreal, Canada; 2022."},{"key":"24935_CR20","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021: Towards ending viral hepatitis. World Health Organization. 2016. Retrieved from https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06. Accessed 9 Nov 2024."},{"key":"24935_CR21","unstructured":"World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030. 2022. Retrieved from: https:\/\/www.who.int\/publications\/i\/item\/9789240053779. Accessed 9 Nov 2024."},{"issue":"3","key":"24935_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/0032885505279373","volume":"85","author":"JF And\u00eda","year":"2005","unstructured":"And\u00eda JF, Deren S, Robles RR, Kang S, Col\u00f3n HM, Oliver-Velez D, et al. Factors associated with injection and non-injection drug use during incarceration among Puerto Rican drug injectors in New York and Puerto Rico. Prison J. 2005;85(3):329\u201342. https:\/\/doi.org\/10.1177\/0032885505279373.","journal-title":"Prison J"},{"key":"24935_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/00938548231207065","volume":"51","author":"MS Johnston","year":"2024","unstructured":"Johnston MS, Ricciardelli R, Whitten C. \u201cThat\u2019s Not Rehabilitation, That\u2019s Enabling\u201d: Correctional Officer Perspectives on the Prison Needle Exchange Program. Crim Justice Behav. 2024;51:66\u201385. https:\/\/doi.org\/10.1177\/00938548231207065.","journal-title":"Crim Justice Behav"},{"issue":"5","key":"24935_CR24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1177\/0032885517728901","volume":"97","author":"E van der Meulen","year":"2017","unstructured":"van der Meulen E, Watson TM, De Shalit A. Insights on prison needle and syringe programs: research with former prisoners in Canada. Prison J. 2017;97(5):628\u201343. https:\/\/doi.org\/10.1177\/0032885517728901.","journal-title":"Prison J"},{"key":"24935_CR25","doi-asserted-by":"crossref","unstructured":"van der Meulen E, Claivaz-Loranger S, Clarke S, Ollner A, Watson TM. On Point: Recommendations for Prison-Based Needle and Syringe Programs in Canada. HIV Legal Network; Toronto, ON. 2016. Retrieved from: https:\/\/www.hivlegalnetwork.ca\/site\/on-point-recommendations-for-prison-based-needle-and-syringe-programs-in-canada\/?lang=en. Accessed 9 Nov 2024.","DOI":"10.32920\/22728362.v1"},{"issue":"1","key":"24935_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssaho.2023.100736","volume":"8","author":"C Whitten","year":"2023","unstructured":"Whitten C, Ricciardelli R, Johnston MS. \u201cWe shouldn\u2019t encourage drug use\u201d: Unpacking correctional officer opposition and support of the Prison Needle Exchange Program. Soc Sci Human Open. 2023;8(1):107736. https:\/\/doi.org\/10.1016\/j.ssaho.2023.100736.","journal-title":"Soc Sci Human Open"},{"key":"24935_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104540","volume":"130","author":"N Kronfli","year":"2024","unstructured":"Kronfli N, Lafferty L, Leone F, Stoov\u00e9 M, Hajarizadeh B, Lloyd AR, et al. Using nominal group technique to identify perceived barriers and facilitators to improving uptake of the Prison Needle Exchange Program in Canadian federal prisons by correctional officers and healthcare workers. Int J Drug Policy. 2024;130:104540. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104540.","journal-title":"Int J Drug Policy"},{"key":"24935_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104549","volume":"131","author":"L Lafferty","year":"2024","unstructured":"Lafferty L, Altice FL, Leone F, Stoov\u00e9 M, Lloyd AR, Hajarizadeh B, et al. Using nominal group technique with people who are incarcerated in Canadian federal prisons to identify barriers and solutions to improving Prison Needle Exchange Program uptake. Int J Drug Policy. 2024;131:104549. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104549.","journal-title":"Int J Drug Policy"},{"key":"24935_CR29","unstructured":"Public Safety Canada. Prison Needle Exchange Program. Retrieved from: https:\/\/www.publicsafety.gc.ca\/cnt\/trnsprnc\/brfng-mtrls\/prlmntry-bndrs\/20200621\/017\/index-en.aspx. Accessed 9 Nov 2024."},{"key":"24935_CR30","volume-title":"Group techniques for program planning - A guide to nominal group and delphi processes","author":"A Delbecq","year":"1975","unstructured":"Delbecq A, Van de Ven A, Gustafson D. Group techniques for program planning - A guide to nominal group and delphi processes. Glenview, IL: Scott, Foresman, and Company; 1975."},{"key":"24935_CR31","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","volume":"311","author":"J Jones","year":"1995","unstructured":"Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311:376\u201380. https:\/\/doi.org\/10.1136\/bmj.311.7001.376.","journal-title":"BMJ"},{"key":"24935_CR32","doi-asserted-by":"crossref","unstructured":"Sav A, McMillan SS, Kelly F, King MA, Whitty JA, Kendall E, Wheeler AJ. Theideal healthcare: Priorities of people with chronic conditions and their carers. BMC Health Serv Res. 2015;15:551.","DOI":"10.1186\/s12913-015-1215-3"},{"key":"24935_CR33","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s11096-016-0257-x","volume":"38","author":"SS McMillan","year":"2016","unstructured":"McMillan SS, King M, Tully MP. How to use the nominal group and Delphi techniques. Int J Clin Pharm. 2016;38:655\u201362. https:\/\/doi.org\/10.1007\/s11096-016-0257-x.","journal-title":"Int J Clin Pharm"},{"key":"24935_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104283","volume":"123","author":"A Mambro","year":"2024","unstructured":"Mambro A, Afshar A, Leone F, Dussault C, Stoov\u00e9 M, Savulescu J, et al. Reimbursing incarcerated individuals for participation in research: a scoping review. Int J Drug Policy. 2024;123:104283. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104283.","journal-title":"Int J Drug Policy"},{"key":"24935_CR35","unstructured":"Correctional Service Canada. Commissioner\u2019s directive 009: Research. 2017. Retrieved from: https:\/\/www.canada.ca\/en\/correctional-service\/corporate\/acts-regulations-policy\/commissioners-directives\/009.html. Accessed 9 Nov 2024."},{"issue":"4","key":"24935_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/109019818801500401","volume":"15","author":"KR McLeroy","year":"1988","unstructured":"McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Q. 1988;15(4):351\u201377. https:\/\/doi.org\/10.1177\/109019818801500401.","journal-title":"Health Educ Q"},{"key":"24935_CR37","unstructured":"Michaels C, Blake L, Lynn A, Greylord T, Benning S. Mental health and well-being ecological model. Center for Leadership Education in Maternal & Child Public Health, University of Minnesota, School of Public Health. 2022. Retrieved from: https:\/\/mch.umn.edu\/resources\/mhecomodel\/. Accessed 9 Nov 2024."},{"issue":"3","key":"24935_CR38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2105\/AJPH.2011.300374","volume":"102","author":"J Pont","year":"2012","unstructured":"Pont J, St\u00f6ver H, Wolff H. Dual loyalty in prison health care. Am J Public Health. 2012;102(3):475\u201380. https:\/\/doi.org\/10.2105\/AJPH.2011.300374.","journal-title":"Am J Public Health"},{"key":"24935_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40352-025-00332-w","volume":"13","author":"L Michaud","year":"2025","unstructured":"Michaud L, Stover H, van de Meulen E, De Shalid A, Chu SKH, Thomas R, et al. Securitizing carceral health: a realist review of Canada\u2019s prison needle exchange program. Health Justice. 2025;13:41. https:\/\/doi.org\/10.1186\/s40352-025-00332-w.","journal-title":"Health Justice."},{"issue":"1","key":"24935_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00399-8","volume":"17","author":"B Muncan","year":"2020","unstructured":"Muncan B, Walters SM, Ezell J, Ompad DC. \u201cThey look at us like junkies\u201d: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17(1):53. https:\/\/doi.org\/10.1186\/s12954-020-00399-8.","journal-title":"Harm Reduct J"},{"issue":"1","key":"24935_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-018-0269-z","volume":"15","author":"D Crowley","year":"2018","unstructured":"Crowley D, Van Hout MC, Lambert JS, Kelly E, Murphy C, Cullen W. Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners\u2019 perspective. Harm Reduct J. 2018;15(1):62. https:\/\/doi.org\/10.1186\/s12954-018-0269-z.","journal-title":"Harm Reduct J"},{"issue":"1","key":"24935_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0313-7","volume":"16","author":"D Crowley","year":"2019","unstructured":"Crowley D, Murtagh R, Cullen W, Keevans M, Laird E, McHugh T, et al. Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners. Harm Reduct J. 2019;16(1):42. https:\/\/doi.org\/10.1186\/s12954-019-0313-7.","journal-title":"Harm Reduct J"},{"issue":"1","key":"24935_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.respe.2022.01.001","volume":"70","author":"C Stasi","year":"2022","unstructured":"Stasi C, Monnini M, Cellesi V, Salvadori M, Marri D, Ameglio M, et al. Ways to promote screening for hepatitis B virus and accelerated vaccination schedule in prison: training, information, peer education. Rev Epidemiol Sante Publique. 2022;70(1):25\u201330. https:\/\/doi.org\/10.1016\/j.respe.2022.01.001.","journal-title":"Rev Epidemiol Sante Publique"},{"key":"24935_CR44","unstructured":"Azbel L, Altice FL. The making of methadone within prisons in the Kyrgyz Republic. Hunt G, Antin TMJ, Frank VA, Eds. London: Taylor & Francis; 2022."},{"issue":"1","key":"24935_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/00914509211060723","volume":"49","author":"L Azbel","year":"2022","unstructured":"Azbel L, Bromberg DJ, Dvoryak S, Altice FL. Addiction treatment as prison governance: a critical discourse analysis of methadone delivery in Kyrgyz prisons. Contemp Drug Probl. 2022;49(1):106\u201320. https:\/\/doi.org\/10.1177\/00914509211060723.","journal-title":"Contemp Drug Probl"},{"key":"24935_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103558","volume":"101","author":"C Bachireddy","year":"2022","unstructured":"Bachireddy C, Shrestha R, Bromberg DJ, Azbel L, Kurmanalieva A, Wegman M, et al. Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: evaluation of a national program. Int J Drug Policy. 2022;101:103558. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103558.","journal-title":"Int J Drug Policy"},{"key":"24935_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103209","volume":"94","author":"AR Liberman","year":"2021","unstructured":"Liberman AR, Bromberg DJ, Azbel L, Rozanova J, Madden L, Meyer JP, et al. Decisional considerations for methadone uptake in Kyrgyz prisons: the importance of understanding context and providing accurate information. Int J Drug Policy. 2021;94:103209. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103209.","journal-title":"Int J Drug Policy"},{"issue":"10","key":"24935_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0276723","volume":"17","author":"AR Liberman","year":"2022","unstructured":"Liberman AR, Bromberg DJ, Litz T, Kurmanalieva A, Galvez S, Rozanova J, et al. Interest without uptake: a mixed-methods analysis of methadone utilization in Kyrgyz prisons. PLoS One. 2022;17(10):e0276723. https:\/\/doi.org\/10.1371\/journal.pone.0276723.","journal-title":"PLoS One"},{"key":"24935_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108660","volume":"136","author":"GL O'Hara","year":"2022","unstructured":"O\u2019Hara GL, Liberman AR, Polonsky M, Azbel L, Marcus R, Doltu S, et al. Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: a qualitative study. J Subst Abuse Treat. 2022;136:108660. https:\/\/doi.org\/10.1016\/j.jsat.2021.108660.","journal-title":"J Subst Abuse Treat"},{"key":"24935_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/1478601X.2023.2275795","volume":"37","author":"R Ricciardelli","year":"2024","unstructured":"Ricciardelli R, Whitten C, Johnston M. \u201cHow are we gonna get them off the drugs if they\u2019re allowed to stay on it?\u201d correctional officer perspectives on Overdose prevention sites in prisons. Crim Just Stud. 2024;37:39\u201358. https:\/\/doi.org\/10.1080\/1478601X.2023.2275795.","journal-title":"Crim Just Stud"},{"key":"24935_CR51","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/s0376-8716(00)00174-5","volume":"62","author":"RN Bluthenthal","year":"2001","unstructured":"Bluthenthal RN, Gogineni A, Longshore D, Stein M. Factors associated with readiness to change drug use among needle-exchange users. Drug Alcohol Depend. 2001;62:225\u201330. https:\/\/doi.org\/10.1016\/s0376-8716(00)00174-5.","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 1","key":"24935_CR52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/00333549141291s105","volume":"129","author":"CK Burr","year":"2014","unstructured":"Burr CK, Storm DS, Hoyt MJ, Dutton L, Berezny L, Allread V, et al. Integrating health and prevention services in syringe access programs: a strategy to address unmet needs in a high-risk population. Public Health Rep. 2014;129(Suppl 1):26\u201332. https:\/\/doi.org\/10.1177\/00333549141291s105.","journal-title":"Public Health Rep"},{"issue":"1","key":"24935_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00381-4","volume":"17","author":"M Castillo","year":"2020","unstructured":"Castillo M, Ginoza MEC, Bartholomew TS, Forrest DW, Greven C, Serota DP, et al. When is an abscess more than an abscess? Syringe services programs and the harm reduction safety-net: a case report. Harm Reduct J. 2020;17(1):34. https:\/\/doi.org\/10.1186\/s12954-020-00381-4.","journal-title":"Harm Reduct J"},{"key":"24935_CR54","unstructured":"Centers for Disease Control and Prevention. HIV and Injection Drug Use: Syringe Services Programs for HIV Prevention. In CDC Vital Signs: U.S. Department of Health & Human Services. 2016. Retrieved from: https:\/\/www.cdc.gov\/vitalsigns\/pdf\/2016-12-vitalsigns.pdf. Accessed 9 Nov 2024."},{"key":"24935_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103570","volume":"101","author":"A Sivakumar","year":"2022","unstructured":"Sivakumar A, Madden L, DiDomizio E, Eller A, Villanueva M, Altice FL. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: the potential role of telehealth, medications for opioid use disorder and minimal demands on patients. Int J Drug Policy. 2022;101:103570. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103570.","journal-title":"Int J Drug Policy"},{"key":"24935_CR56","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/bf02351502","volume":"76","author":"SA Strathdee","year":"1999","unstructured":"Strathdee SA, Celentano DD, Shah N, Lyles C, Stambolis VA, Macalino G, et al. Needle-exchange attendance and health care utilization promote entry into detoxification. J Urban Health. 1999;76:448\u201360. https:\/\/doi.org\/10.1007\/bf02351502.","journal-title":"J Urban Health"},{"key":"24935_CR57","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.vaccine.2023.01.040","volume":"41","author":"T Zolotarova","year":"2023","unstructured":"Zolotarova T, Dussault C, Park H, Varsaneux O, Basta NE, Watson L, et al. Education increases COVID-19 vaccine uptake among people in Canadian federal prisons in a prospective randomized controlled trial: the EDUCATE study. Vaccine. 2023;41:1419\u201325. https:\/\/doi.org\/10.1016\/j.vaccine.2023.01.040.","journal-title":"Vaccine"},{"issue":"1","key":"24935_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/ijerph21010045","volume":"21","author":"M Della Bona","year":"2023","unstructured":"Della Bona M, Crawford G, Royce B, Jancey J, Leavy JE. (2024) Using ERIC to assess implementation science in drowning prevention interventions in high-income countries: a systematic review. Int J Environ Res Public Health. 2023;21(1):45. https:\/\/doi.org\/10.3390\/ijerph21010045.","journal-title":"Int J Environ Res Public Health."},{"issue":"4","key":"24935_CR59","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1353\/hpu.2018.0111","volume":"29","author":"K Thornton","year":"2018","unstructured":"Thornton K, Sedillo ML, Kalishman S, Page K, Arora S. The new Mexico peer education project: filling a critical gap in HCV prison education. J Health Care Poor Underserved. 2018;29(4):1544\u201357. https:\/\/doi.org\/10.1353\/hpu.2018.0111.","journal-title":"J Health Care Poor Underserved"},{"key":"24935_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1584-x","volume":"15","author":"AM Bagnall","year":"2015","unstructured":"Bagnall AM, South J, Hulme C, Woodall J, Vinall-Collier K, Raine G, et al. A systematic review of the effectiveness and cost-effectiveness of peer education and peer support in prisons. BMC Public Health. 2015;15:290. https:\/\/doi.org\/10.1186\/s12889-015-1584-x.","journal-title":"BMC Public Health"},{"key":"24935_CR61","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s10742-014-0121-1","volume":"14","author":"SS McMillan","year":"2014","unstructured":"McMillan SS, Kelly F, Sav A, Kendall E, King MA, Whitty JA, et al. Using the nominal group technique: how to analyse across multiple groups. Health Serv Outcomes Res Methodol. 2014;14:92\u2013108. https:\/\/doi.org\/10.1007\/s10742-014-0121-1.","journal-title":"Health Serv Outcomes Res Methodol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-24935-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:53:56Z","timestamp":1761742436000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-24935-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24935"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-24935-y","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the McGill University Health Centre Research Ethics Board (#2023\u20139201). The study adhered to the Declaration of Helsinki. Informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FL, BH, and FLA report no competing interest. NK has received research funding from ViiV Healthcare, Abbvie, and Gilead, advisory fees from Gilead Sciences, ViiV Healthcare, Merck, and Abbvie, and speaker fees from Gilead Sciences, Abbvie, and Merck, all outside this work. LL has received speaker fees from AbbVie Pty Ltd unrelated to this work. FL has no disclosure. MS has received investigator-initiated research funding from Gilead Sciences and AbbVie and consultant fees from Gilead Sciences for activities unrelated to this work. ARL has received investigator-initiated research support from Gilead and AbbVie, outside this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3652"}}